Progranulin-associated PiB-negative logopenic primary progressive aphasia

Journal of Neurology

Volumn 261, Issue 3, 2014, Pages 604-614

  Josephs, Keith A ^a   Duffy, Joseph R ^a   Strand, Edythe A ^a   Machulda, Mary M ^a   Vemuri, Prashanthi ^a   Senjem, Matthew L ^a   Perkerson, Ralph B ^b   Baker, Matthew C ^b   Lowe, Val ^a   Jack, Clifford R ^a   Rademakers, Rosa ^b   Whitwell, Jennifer L ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

FDG PET; Logopenic; MRI; Primary progressive aphasia; Progranulin; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; DNA; FLUORODEOXYGLUCOSE F 18; PITTSBURGH COMPOUND B; PROGRANULIN; 2-(4'-(METHYLAMINO)PHENYL)-6-HYDROXYBENZOTHIAZOLE; ANILINE DERIVATIVE; APOLIPOPROTEIN E; GRN PROTEIN, HUMAN; SIGNAL PEPTIDE; THIAZOLE DERIVATIVE;

ADULT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN METABOLISM; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; EXON; FAMILY HISTORY; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE MAPPING; GENE MUTATION; GENETIC SCREENING; GRAY MATTER; GRAY MATTER ATROPHY; HUMAN; LANGUAGE DISABILITY; LOGOPENIC PRIMARY PROGRESSIVE APHASIA; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROLOGY; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SPEECH DISORDER; TEMPORAL LOBE; YOUNG ADULT; AGE; ATROPHY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DEVICES; DIAGNOSTIC USE; GENETICS; LANGUAGE TEST; METABOLISM; MIDDLE AGED; MULTIMODAL IMAGING; MUTATION; NEUROPSYCHOLOGICAL TEST; PARIETAL LOBE; PATHOLOGY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES;

AGE FACTORS; AGED; AMYLOID BETA-PEPTIDES; ANILINE COMPOUNDS; APHASIA, PRIMARY PROGRESSIVE; APOLIPOPROTEINS E; ATROPHY; CEREBRAL CORTEX; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LANGUAGE TESTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; MUTATION; NEUROPSYCHOLOGICAL TESTS; PARIETAL LOBE; POSITRON-EMISSION TOMOGRAPHY; TEMPORAL LOBE; THIAZOLES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84896490663     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7243-9     Document Type: Article

References (51)

1. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF et al (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006-1014
2. Josephs KA, Duffy JR, Fossett TR, Strand EA, Claassen DO, Whitwell JL et al (2010) Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants. Arch Neurol 67:596-605
3. Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, Rosen HJ et al (2004) Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 55:335-346
4. Leyton CE, Villemagne VL, Savage S, Pike KE, Ballard KJ, Piguet O et al (2011) Subtypes of progressive aphasia: application of the international consensus criteria and validation using beta-amyloid imaging. Brain J Neurol 134:3030-3043
5. Mesulam M, Wicklund A, Johnson N, Rogalski E, Leger GC, Rademaker A et al (2008) Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol 63:709-719
6. Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC et al (2008) Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 64:388-401
7. Deramecourt V, Lebert F, Debachy B, Mackowiak-Cordoliani MA, Bombois S, Kerdraon O et al (2010) Prediction of pathology in primary progressive language and speech disorders. Neurology 74:42-49
8. Josephs KA, Duffy JR, Strand EA, Whitwell JL, Layton KF, Parisi JE et al (2006) Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 129:1385-1398
9. Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM et al (2011) Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol 122:137-153
10. Teichmann M, Kas A, Boutet C, Ferrieux S, Nogues M, Samri D et al (2013) Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation. Brain 136:3474-3488
11. Rohrer JD, Crutch SJ, Warrington EK, Warren JD (2010) Progranulin-associated primary progressive aphasia: a distinct phenotype? Neuropsychologia 48:288-297
12. Josephs KA, Duffy JR, Strand EA, Machulda MM, Senjem ML, Master AV et al (2012) Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain J Neurol 135:1522-1536
13. Josephs KA, Duffy JR, Strand EA, Machulda MM, Senjem ML, Lowe VJ et al (2013) Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA. Neurology 81:337-345
14. Kertesz A (2007) Western Aphasia Battery (Revised). PsychCorp, San Antonio
15. De Renzi E, Vignolo LA (1962) The token test: a sensitive test to detect receptive disturbances in aphasics. Brain 85:665-678
16. Lansing AE, Ivnik RJ, Cullum CM, Randolph C (1999) An empirically derived short form of the Boston naming test. Arch Clin Neuropsychol 14:481-487
17. Woods SP, Scott JC, Sires DA, Grant I, Heaton RK, Troster AI (2005) Action (verb) fluency: test-retest reliability, normative standards, and construct validity. J Int Neuropsychol Soc 11:408-415
18. Loonstra AS, Tarlow AR, Sellers AH (2001) COWAT metanorms across age, education, and gender. Appl Neuropsychol 8:161-166
19. Howard D, Patterson K (1992) The pyramids and palm trees test: a test of semantic access from words and picture. Thames Valley Test Company, Bury St Edmunds, UK
20. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I et al (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695-699
21. Kertesz A, Davidson W, Fox H (1997) Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci 24:29-36
22. Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T et al (2000) Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. J Neuropsychiatry Clin Neurosci 12:233-239
23. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P et al (2008) Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord Off J Mov Disord Soc 23:2129-2170
24. Spreen O, Strauss E (1991) A compendium of neuropsychological tests: administration, norms, and commentary. Oxford University Press, New York
25. Delis D, Kaplan E, Kramer J (2001) Delis-Kaplan executive function system (DKEFS): examiner's manual. The Psychological Corporation, San Antonio
26. Rey A (1964) L'examen clinique en psychologie. Presses Universitaires de France, Paris
27. Warrington E, James M (1991) The visual object and space perception battery. Thames Valley Test Company, Bury St Edmonds
28. Osterrieth PA (1944) Le test de copie d'une figure complexe. Archives de Psychologie 30:206-356
29. Ivnik RJ, Malec J, Smith GE, Tangalos EG, Petersen RC, Kokmen E (1992) Mayo's older American normative studies: WAIS-R, WMS-R and AVLT norms for ages 56-97. Clin Neuropsychol 6(supplement):1-104
30. Josephs KA, Tsuboi Y, Cookson N, Watt H, Dickson DW (2004) Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration. Arch Neurol 61:1579-1584
31. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C et al (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442:916-919
32. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J et al (2006) Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 15:2988-3001
33. Jack CR Jr, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM et al (2008) 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 131:665-680
34. Vemuri P, Simon G, Kantarci K, Whitwell JL, Senjem ML, Przybelski SA et al (2011) Antemortem differential diagnosis of dementia pathology using structural MRI: differential-STAND. Neuroimage 55:522-531
35. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE (1995) A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36:1238-1248
36. Ashburner J, Friston KJ (2000) Voxel-based morphometry - the methods. Neuroimage 11:805-821
37. Ashburner J, Friston KJ (2005) Unified segmentation. Neuroimage 26:839-851
38. Madhavan A, Whitwell JL, Weigand SD, Duffy JR, Strand EA, Machulda MM et al (2013) FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type. PLoS One 8:62471
39. Chan D, Fox NC, Scahill RI, Crum WR, Whitwell JL, Leschziner G et al (2001) Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol 49:433-442
40. Machulda MM, Whitwell JL, Duffy JR, Strand EA, Dean PM, Senjem ML et al (2013) Identification of an atypical variant of logopenic progressive aphasia. Brain Lang 127(2):139-144
41. Josephs KA, Whitwell JL, Vemuri P, Senjem ML, Boeve BF, Knopman DS et al (2008) The anatomic correlate of prosopagnosia in semantic dementia. Neurology 71:1628-1633
42. Whitwell JL, Jack CR Jr, Baker M, Rademakers R, Adamson J, Boeve BF et al (2007) Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. Arch Neurol 64:371-376
43. Skoglund L, Brundin R, Olofsson T, Kalimo H, Ingvast S, Blom ES et al (2009) Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutation. Neurogenetics 10:27-34
44. Pickering-Brown SM, Rollinson S, Du Plessis D, Morrison KE, Varma A, Richardson AM et al (2008) Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain 131:721-731
45. Rohrer JD, Ridgway GR, Crutch SJ, Hailstone J, Goll JC, Clarkson MJ et al (2010) Progressive logopenic/phonological aphasia: erosion of the language network. Neuroimage 49:984-993
46. Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T et al (2012) Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 135:736-750
47. Whitwell JL, Weigand SD, Gunter JL, Boeve BF, Rademakers R, Baker M et al (2011) Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN. Neurology 77:393-398
48. Whitwell JL, Weigand SD, Boeve BF, Senjem ML, Gunter JL, DeJesus-Hernandez M et al (2012) Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain 135:794-806
49. Beck J, Rohrer JD, Campbell T, Isaacs A, Morrison KE, Goodall EF et al (2008) A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain 131:706-720
50. Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E et al (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122:111-113
51. Bigio EH (2008) Update on recent molecular and genetic advances in frontotemporal lobar degeneration. J Neuropathol Exp Neurol 67:635-648